Investors’ “sceptical” of Axa XL performance in the short-term: Jefferies

Investors remain sceptical of Axa’s $15.3bn purchase of Bermudian specialty (re)insurer XL Group in the short-term but a hardening rate environment and the better than expected integration of the unit should drive growth and ally fears, according to analysis from Jefferies.